Jemperli® (dostarlimab-gxly)
for Solid Tumors General

Jemperli (dostarlimab-gxly) is an immunotherapy used to treat certain types of endometrial cancer and solid tumors. As a PD-1–blocking antibody, it reactivates T-cells by preventing the PD-1 protein from inactivating them, enabling the immune system to detect and destroy cancer cells.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Solid Tumors General